Literature DB >> 29937375

Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.

Gantsetseg Tumurkhuu1, Jargalsaikhan Dagvadorj1, Rebecca A Porritt1, Timothy R Crother2, Kenichi Shimada2, Elizabeth J Tarling3, Ebru Erbay4, Moshe Arditi5, Shuang Chen2.   

Abstract

Pathogen burden accelerates atherosclerosis, but the mechanisms remain unresolved. Activation of the NLRP3 inflammasome is linked to atherogenesis. Here we investigated whether Chlamydia pneumoniae (C.pn) infection engages NLRP3 in promoting atherosclerosis. C.pn potentiated hyperlipidemia-induced inflammasome activity in cultured macrophages and in foam cells in atherosclerotic lesions of Ldlr-/- mice. C.pn-induced acceleration of atherosclerosis was significantly dependent on NLRP3 and caspase-1. We discovered that C.pn-induced extracellular IL-1β triggers a negative feedback loop to inhibit GPR109a and ABCA1 expression and cholesterol efflux, leading to accumulation of intracellular cholesterol and foam cell formation. Gpr109a and Abca1 were both upregulated in plaque lesions in Nlrp3-/- mice in both hyperlipidemic and C.pn infection models. Mature IL-1β and cholesterol may compete for access to the ABCA1 transporter to be exported from macrophages. C.pn exploits this metabolic-immune crosstalk, which can be modulated by NLRP3 inhibitors to alleviate atherosclerosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCA1; C. pneumoniae; Gpr109a; Nlrp3; aspartate; atherosclerosis; cholesterol efflux; foam cells; interleukin-1 beta; niacin

Mesh:

Substances:

Year:  2018        PMID: 29937375      PMCID: PMC6125162          DOI: 10.1016/j.cmet.2018.05.027

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  64 in total

1.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Authors:  Shuang Chen; Kenichi Shimada; Timothy R Crother; Ebru Erbay; Prediman K Shah; Moshe Arditi
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

Review 2.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

3.  Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice.

Authors:  Jessica Gage; Mirela Hasu; Mohamed Thabet; Stewart C Whitman
Journal:  Can J Cardiol       Date:  2012-01-21       Impact factor: 5.223

4.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.

Authors:  Peder S Olofsson; Yuri Sheikine; Ken Jatta; Mehran Ghaderi; Ann Samnegård; Per Eriksson; Allan Sirsjö
Journal:  Circ J       Date:  2009-07-03       Impact factor: 2.993

Review 7.  Ketone bodies as signaling metabolites.

Authors:  John C Newman; Eric Verdin
Journal:  Trends Endocrinol Metab       Date:  2013-10-18       Impact factor: 12.015

Review 8.  Mechanisms of interleukin-1beta release.

Authors:  Claudia Eder
Journal:  Immunobiology       Date:  2009-02-27       Impact factor: 3.144

Review 9.  Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?

Authors:  Lee Ann Campbell; Cho-cho Kuo
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 10.  Infectious burden: a new risk factor and treatment target for atherosclerosis.

Authors:  Mitchell S V Elkind
Journal:  Infect Disord Drug Targets       Date:  2010-04
View more
  20 in total

Review 1.  Foam Cells: One Size Doesn't Fit All.

Authors:  Valentina Guerrini; Maria Laura Gennaro
Journal:  Trends Immunol       Date:  2019-11-12       Impact factor: 16.687

2.  STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells.

Authors:  Taylor T Chrisikos; Yifan Zhou; Laura M Kahn; Bhakti Patel; Nina L Denne; Athena Brooks; Li Shen; Jing Wang; Stephanie S Watowich
Journal:  J Immunol       Date:  2022-08-29       Impact factor: 5.426

Review 3.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

4.  Phenotype and Response to PAMPs of Human Monocyte-Derived Foam Cells Obtained by Long-Term Culture in the Presence of oxLDLs.

Authors:  Anna Nogieć; Małgorzata Bzowska; Agnieszka Demczuk; Chen Varol; Krzysztof Guzik
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

Review 5.  NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.

Authors:  Yucheng Wang; Xiaoxiao Liu; Hui Shi; Yong Yu; Ying Yu; Minghui Li; Ruizhen Chen
Journal:  Clin Transl Med       Date:  2020-04-09

Review 6.  The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.

Authors:  Rongrong Bai; Yue Lang; Jie Shao; Yu Deng; Reyisha Refuhati; Li Cui
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 7.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

8.  Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice.

Authors:  Shuang Chen; Janet L Markman; Kenichi Shimada; Timothy R Crother; Malcolm Lane; Amanda Abolhesn; Prediman K Shah; Moshe Arditi
Journal:  JACC Basic Transl Sci       Date:  2020-05-20

Review 9.  Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections.

Authors:  Yi Ying Cheok; Chalystha Yie Qin Lee; Heng Choon Cheong; Chung Yeng Looi; Won Fen Wong
Journal:  Microorganisms       Date:  2020-01-17

Review 10.  Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease.

Authors:  Nan Ji; Zhongwen Qi; Yueyao Wang; Xiaoya Yang; Zhipeng Yan; Meng Li; Qihui Ge; Junping Zhang
Journal:  J Inflamm Res       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.